AHB-137 injection
Sponsors
AusperBio Therapeutics Inc., Ausper Biopharma Co., Ltd.
Conditions
Chronic Hepatitis BHepatitis B, Chronic
Phase 1
A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B
CompletedNCT05717686
Start: 2023-02-28End: 2025-01-07Updated: 2025-02-14
A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients
CompletedNCT06115993
Start: 2023-08-03End: 2025-11-10Updated: 2026-05-07
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
RecruitingNCT07600788
Start: 2026-07-09End: 2028-05-15Target: 32Updated: 2026-07-29